MA7D1_HUMAN - dbPTM
MA7D1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MA7D1_HUMAN
UniProt AC Q3KQU3
Protein Name MAP7 domain-containing protein 1
Gene Name MAP7D1
Organism Homo sapiens (Human).
Sequence Length 841
Subcellular Localization Cytoplasm, cytoskeleton, spindle .
Protein Description
Protein Sequence MESGPRAELGAGAPPAVVARTPPEPRPSPEGDPSPPPPPMSALVPDTPPDTPPAMKNATSSKQLPLEPESPSGQVGPRPAPPQEESPSSEAKSRGPTPPAMGPRDARPPRRSSQPSPTAVPASDSPPTKQEVKKAGERHKLAKERREERAKYLAAKKAVWLEKEEKAKALREKQLQERRRRLEEQRLKAEQRRAALEERQRQKLEKNKERYEAAIQRSVKKTWAEIRQQRWSWAGALHHSSPGHKTSGSRCSVSAVNLPKHVDSIINKRLSKSSATLWNSPSRNRSLQLSAWESSIVDRLMTPTLSFLARSRSAVTLPRNGRDQGRGCDPGRGPTWGRAGASLARGPQPDRTHPSAAVPVCPRSASASPLTPCSVTRSVHRCAPAGERGERRKPNAGGSPAPVRRRPEASPVQKKEKKDKERENEKEKSALARERSLKKRQSLPASPRARLSASTASELSPKSKARPSSPSTSWHRPASPCPSPGPGHTLPPKPPSPRGTTASPKGRVRRKEEAKESPSAAGPEDKSQSKRRASNEKESAAPASPAPSPAPSPTPAPPQKEQPPAETPTDAAVLTSPPAPAPPVTPSKPMAGTTDREEATRLLAEKRRQAREQREREEQERRLQAERDKRMREEQLAREAEARAEREAEARRREEQEAREKAQAEQEEQERLQKQKEEAEARSREEAERQRLEREKHFQQQEQERQERRKRLEEIMKRTRKSEVSETKQKQDSKEANANGSSPEPVKAVEARSPGLQKEAVQKEEPIPQEPQWSLPSKELPASLVNGLQPLPAHQENGFSTNGPSGDKSLSRTPETLLPFAEAEAFLKKAVVQSPQVTEVL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8 (in isoform 3)Ubiquitination-49.36-
14 (in isoform 3)Phosphorylation-19.2325159151
15 (in isoform 3)Phosphorylation-36.8325159151
21PhosphorylationPPAVVARTPPEPRPS
CCEEEECCCCCCCCC
33.2023927012
28PhosphorylationTPPEPRPSPEGDPSP
CCCCCCCCCCCCCCC
36.5423927012
34PhosphorylationPSPEGDPSPPPPPMS
CCCCCCCCCCCCCCH
55.5725159151
41PhosphorylationSPPPPPMSALVPDTP
CCCCCCCHHCCCCCC
24.9929255136
47PhosphorylationMSALVPDTPPDTPPA
CHHCCCCCCCCCCCH
30.5629255136
51PhosphorylationVPDTPPDTPPAMKNA
CCCCCCCCCCHHCCC
36.6229255136
59PhosphorylationPPAMKNATSSKQLPL
CCHHCCCCCCCCCCC
42.8223312004
60PhosphorylationPAMKNATSSKQLPLE
CHHCCCCCCCCCCCC
32.8823312004
61PhosphorylationAMKNATSSKQLPLEP
HHCCCCCCCCCCCCC
21.7723312004
70PhosphorylationQLPLEPESPSGQVGP
CCCCCCCCCCCCCCC
34.7729255136
72PhosphorylationPLEPESPSGQVGPRP
CCCCCCCCCCCCCCC
51.6529255136
86PhosphorylationPAPPQEESPSSEAKS
CCCCCCCCCCHHHHH
29.3629255136
88PhosphorylationPPQEESPSSEAKSRG
CCCCCCCCHHHHHCC
50.5229255136
89PhosphorylationPQEESPSSEAKSRGP
CCCCCCCHHHHHCCC
44.9829255136
93PhosphorylationSPSSEAKSRGPTPPA
CCCHHHHHCCCCCCC
49.9023927012
97PhosphorylationEAKSRGPTPPAMGPR
HHHHCCCCCCCCCCC
44.7423927012
112PhosphorylationDARPPRRSSQPSPTA
CCCCCCCCCCCCCCC
34.3129255136
113PhosphorylationARPPRRSSQPSPTAV
CCCCCCCCCCCCCCC
44.2829255136
113 (in isoform 3)Phosphorylation-44.2822199227
115 (in isoform 3)Phosphorylation-44.2022199227
116PhosphorylationPRRSSQPSPTAVPAS
CCCCCCCCCCCCCCC
27.5229255136
118PhosphorylationRSSQPSPTAVPASDS
CCCCCCCCCCCCCCC
44.6229255136
122 (in isoform 3)Phosphorylation-21.2622199227
123PhosphorylationSPTAVPASDSPPTKQ
CCCCCCCCCCCCCHH
32.3323927012
124 (in isoform 3)Phosphorylation-68.2325850435
125PhosphorylationTAVPASDSPPTKQEV
CCCCCCCCCCCHHHH
30.2219664994
128PhosphorylationPASDSPPTKQEVKKA
CCCCCCCCHHHHHHH
49.0630266825
130 (in isoform 3)Phosphorylation-64.2925850435
131 (in isoform 3)Phosphorylation-58.8425850435
151AcetylationERREERAKYLAAKKA
HHHHHHHHHHHHHHH
47.2025953088
156AcetylationRAKYLAAKKAVWLEK
HHHHHHHHHHHHHCH
35.3419816235
157AcetylationAKYLAAKKAVWLEKE
HHHHHHHHHHHHCHH
43.3719816243
157UbiquitinationAKYLAAKKAVWLEKE
HHHHHHHHHHHHCHH
43.37-
166AcetylationVWLEKEEKAKALREK
HHHCHHHHHHHHHHH
57.1719816251
211PhosphorylationLEKNKERYEAAIQRS
HHHHHHHHHHHHHHH
15.83-
232PhosphorylationEIRQQRWSWAGALHH
HHHHHHHCHHHHHCC
14.8328176443
240PhosphorylationWAGALHHSSPGHKTS
HHHHHCCCCCCCCCC
27.7228176443
241PhosphorylationAGALHHSSPGHKTSG
HHHHCCCCCCCCCCC
30.4628176443
246PhosphorylationHSSPGHKTSGSRCSV
CCCCCCCCCCCCCEE
32.4223312004
247PhosphorylationSSPGHKTSGSRCSVS
CCCCCCCCCCCCEEE
39.3026434776
249PhosphorylationPGHKTSGSRCSVSAV
CCCCCCCCCCEEEEC
29.8526434776
252PhosphorylationKTSGSRCSVSAVNLP
CCCCCCCEEEECCCC
20.2825159151
254PhosphorylationSGSRCSVSAVNLPKH
CCCCCEEEECCCCHH
15.3725159151
256 (in isoform 3)Phosphorylation-6.1922210691
259 (in isoform 3)Phosphorylation-21.3622210691
260UbiquitinationVSAVNLPKHVDSIIN
EEECCCCHHHHHHHH
60.47-
264PhosphorylationNLPKHVDSIINKRLS
CCCHHHHHHHHHHCC
25.0328857561
268UbiquitinationHVDSIINKRLSKSSA
HHHHHHHHHCCCCCC
44.29-
271PhosphorylationSIINKRLSKSSATLW
HHHHHHCCCCCCCCC
34.2323401153
272UbiquitinationIINKRLSKSSATLWN
HHHHHCCCCCCCCCC
53.6921890473
272 (in isoform 1)Ubiquitination-53.6921890473
272 (in isoform 4)Ubiquitination-53.6921890473
273PhosphorylationINKRLSKSSATLWNS
HHHHCCCCCCCCCCC
23.1023401153
274PhosphorylationNKRLSKSSATLWNSP
HHHCCCCCCCCCCCC
29.0728176443
276PhosphorylationRLSKSSATLWNSPSR
HCCCCCCCCCCCCCC
33.9628176443
277 (in isoform 3)Phosphorylation-4.0025159151
278 (in isoform 3)Phosphorylation-10.0125849741
280PhosphorylationSSATLWNSPSRNRSL
CCCCCCCCCCCCCCC
16.8122167270
282PhosphorylationATLWNSPSRNRSLQL
CCCCCCCCCCCCCCH
41.8422167270
286PhosphorylationNSPSRNRSLQLSAWE
CCCCCCCCCCHHHHH
24.8228464451
290PhosphorylationRNRSLQLSAWESSIV
CCCCCCHHHHHHHHH
20.5528450419
294PhosphorylationLQLSAWESSIVDRLM
CCHHHHHHHHHHHHH
18.0530619164
295PhosphorylationQLSAWESSIVDRLMT
CHHHHHHHHHHHHHC
18.3430619164
302PhosphorylationSIVDRLMTPTLSFLA
HHHHHHHCHHHHHHH
20.0821712546
304PhosphorylationVDRLMTPTLSFLARS
HHHHHCHHHHHHHHC
26.3526434776
306PhosphorylationRLMTPTLSFLARSRS
HHHCHHHHHHHHCCC
22.2328857561
310MethylationPTLSFLARSRSAVTL
HHHHHHHHCCCCEEC
34.45115386781
311PhosphorylationTLSFLARSRSAVTLP
HHHHHHHCCCCEECC
25.6123927012
313PhosphorylationSFLARSRSAVTLPRN
HHHHHCCCCEECCCC
28.4730266825
313 (in isoform 4)Phosphorylation-28.4729507054
316PhosphorylationARSRSAVTLPRNGRD
HHCCCCEECCCCCCC
30.6623927012
316 (in isoform 4)Phosphorylation-30.6629507054
326MethylationRNGRDQGRGCDPGRG
CCCCCCCCCCCCCCC
36.6182955203
332MethylationGRGCDPGRGPTWGRA
CCCCCCCCCCCCCCC
53.99115492383
342PhosphorylationTWGRAGASLARGPQP
CCCCCCHHHCCCCCC
22.9523312004
352PhosphorylationRGPQPDRTHPSAAVP
CCCCCCCCCCCCCCC
45.5828555341
355PhosphorylationQPDRTHPSAAVPVCP
CCCCCCCCCCCCCCC
22.66-
364PhosphorylationAVPVCPRSASASPLT
CCCCCCCCCCCCCCC
16.2422167270
366PhosphorylationPVCPRSASASPLTPC
CCCCCCCCCCCCCCC
30.4422167270
368PhosphorylationCPRSASASPLTPCSV
CCCCCCCCCCCCCCC
20.2522167270
371PhosphorylationSASASPLTPCSVTRS
CCCCCCCCCCCCCCC
26.1527273156
374PhosphorylationASPLTPCSVTRSVHR
CCCCCCCCCCCCHHC
27.9422167270
376PhosphorylationPLTPCSVTRSVHRCA
CCCCCCCCCCHHCCC
10.8423403867
399PhosphorylationRKPNAGGSPAPVRRR
CCCCCCCCCCCCCCC
19.5729255136
410PhosphorylationVRRRPEASPVQKKEK
CCCCCCCCCCCCHHH
24.7623401153
414AcetylationPEASPVQKKEKKDKE
CCCCCCCCHHHHHHH
64.2312656543
415AcetylationEASPVQKKEKKDKER
CCCCCCCHHHHHHHH
58.6412656553
436PhosphorylationSALARERSLKKRQSL
HHHHHHHHHHHHHCC
39.5326074081
439UbiquitinationARERSLKKRQSLPAS
HHHHHHHHHHCCCCC
62.0517370265
442PhosphorylationRSLKKRQSLPASPRA
HHHHHHHCCCCCHHH
40.1123927012
446PhosphorylationKRQSLPASPRARLSA
HHHCCCCCHHHHHCC
16.9929255136
452PhosphorylationASPRARLSASTASEL
CCHHHHHCCCCHHHC
18.0230266825
454PhosphorylationPRARLSASTASELSP
HHHHHCCCCHHHCCC
22.5630266825
455PhosphorylationRARLSASTASELSPK
HHHHCCCCHHHCCCC
33.6430266825
457PhosphorylationRLSASTASELSPKSK
HHCCCCHHHCCCCCC
38.8822167270
460O-linked_GlycosylationASTASELSPKSKARP
CCCHHHCCCCCCCCC
26.6530379171
460PhosphorylationASTASELSPKSKARP
CCCHHHCCCCCCCCC
26.6519664994
462SumoylationTASELSPKSKARPSS
CHHHCCCCCCCCCCC
62.3028112733
463PhosphorylationASELSPKSKARPSSP
HHHCCCCCCCCCCCC
34.6327174698
468PhosphorylationPKSKARPSSPSTSWH
CCCCCCCCCCCCCCC
49.6923927012
469PhosphorylationKSKARPSSPSTSWHR
CCCCCCCCCCCCCCC
26.0823927012
471PhosphorylationKARPSSPSTSWHRPA
CCCCCCCCCCCCCCC
36.7023927012
472PhosphorylationARPSSPSTSWHRPAS
CCCCCCCCCCCCCCC
38.9423927012
473PhosphorylationRPSSPSTSWHRPASP
CCCCCCCCCCCCCCC
25.8123927012
479PhosphorylationTSWHRPASPCPSPGP
CCCCCCCCCCCCCCC
29.7129255136
483PhosphorylationRPASPCPSPGPGHTL
CCCCCCCCCCCCCCC
49.5629255136
489PhosphorylationPSPGPGHTLPPKPPS
CCCCCCCCCCCCCCC
47.0429255136
496PhosphorylationTLPPKPPSPRGTTAS
CCCCCCCCCCCCCCC
35.4429255136
500PhosphorylationKPPSPRGTTASPKGR
CCCCCCCCCCCCCCC
22.0728176443
501PhosphorylationPPSPRGTTASPKGRV
CCCCCCCCCCCCCCC
28.1426699800
503PhosphorylationSPRGTTASPKGRVRR
CCCCCCCCCCCCCCC
25.6726699800
517PhosphorylationRKEEAKESPSAAGPE
CHHHHHCCCCCCCCC
24.3729255136
519PhosphorylationEEAKESPSAAGPEDK
HHHHCCCCCCCCCCH
39.7819691289
529PhosphorylationGPEDKSQSKRRASNE
CCCCHHHHHHHHHCH
34.91-
534PhosphorylationSQSKRRASNEKESAA
HHHHHHHHCHHCCCC
43.6523401153
539PhosphorylationRASNEKESAAPASPA
HHHCHHCCCCCCCCC
40.5829255136
544PhosphorylationKESAAPASPAPSPAP
HCCCCCCCCCCCCCC
22.1229255136
548PhosphorylationAPASPAPSPAPSPTP
CCCCCCCCCCCCCCC
35.4829255136
552PhosphorylationPAPSPAPSPTPAPPQ
CCCCCCCCCCCCCCC
43.4429255136
554PhosphorylationPSPAPSPTPAPPQKE
CCCCCCCCCCCCCCC
36.1029255136
567PhosphorylationKEQPPAETPTDAAVL
CCCCCCCCCCCCCHH
33.3327174698
569PhosphorylationQPPAETPTDAAVLTS
CCCCCCCCCCCHHCC
45.7725159151
575PhosphorylationPTDAAVLTSPPAPAP
CCCCCHHCCCCCCCC
32.3729255136
576PhosphorylationTDAAVLTSPPAPAPP
CCCCHHCCCCCCCCC
25.4029255136
585PhosphorylationPAPAPPVTPSKPMAG
CCCCCCCCCCCCCCC
27.8429255136
587PhosphorylationPAPPVTPSKPMAGTT
CCCCCCCCCCCCCCC
39.7729255136
593PhosphorylationPSKPMAGTTDREEAT
CCCCCCCCCCHHHHH
18.9129255136
594PhosphorylationSKPMAGTTDREEATR
CCCCCCCCCHHHHHH
31.9429255136
600PhosphorylationTTDREEATRLLAEKR
CCCHHHHHHHHHHHH
25.7329978859
682 (in isoform 2)Phosphorylation-27.9622210691
685 (in isoform 2)Phosphorylation-63.9122210691
687 (in isoform 4)Phosphorylation-16.7222210691
690 (in isoform 4)Phosphorylation-45.9022210691
703 (in isoform 2)Phosphorylation-47.0025159151
704 (in isoform 2)Phosphorylation-56.4225849741
708 (in isoform 4)Phosphorylation-40.8725159151
709 (in isoform 4)Phosphorylation-27.9125849741
733PhosphorylationETKQKQDSKEANANG
HHHHHHHHHHHHCCC
29.8720068231
741PhosphorylationKEANANGSSPEPVKA
HHHHCCCCCCCCHHH
42.3923401153
742PhosphorylationEANANGSSPEPVKAV
HHHCCCCCCCCHHHH
34.3829255136
753PhosphorylationVKAVEARSPGLQKEA
HHHHHCCCCCCHHHH
30.3028355574
777PhosphorylationEPQWSLPSKELPASL
CCCCCCCCCCCCHHH
44.0224719451
800PhosphorylationAHQENGFSTNGPSGD
CHHCCCCCCCCCCCC
23.5126074081
801PhosphorylationHQENGFSTNGPSGDK
HHCCCCCCCCCCCCC
41.7726074081
805PhosphorylationGFSTNGPSGDKSLSR
CCCCCCCCCCCCCCC
62.1126074081
809PhosphorylationNGPSGDKSLSRTPET
CCCCCCCCCCCCHHH
36.0025159151
811PhosphorylationPSGDKSLSRTPETLL
CCCCCCCCCCHHHHH
40.9925159151
813PhosphorylationGDKSLSRTPETLLPF
CCCCCCCCHHHHHHH
23.3130278072
816PhosphorylationSLSRTPETLLPFAEA
CCCCCHHHHHHHHHH
34.4925159151
828UbiquitinationAEAEAFLKKAVVQSP
HHHHHHHHHHHHCCC
32.03-
834PhosphorylationLKKAVVQSPQVTEVL
HHHHHHCCCCCCCCC
12.9930266825
838O-linked_GlycosylationVVQSPQVTEVL----
HHCCCCCCCCC----
18.3530379171
838PhosphorylationVVQSPQVTEVL----
HHCCCCCCCCC----
18.3530266825

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MA7D1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MA7D1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MA7D1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
APOA1_HUMANAPOA1physical
16169070
RBM48_HUMANRBM48physical
16169070
GASP1_HUMANGPRASP1physical
16169070
CSN6_HUMANCOPS6physical
16169070

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MA7D1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-460; SER-544AND SER-548, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72; SER-86; THR-118;SER-460; SER-544; SER-548; SER-552; THR-554 AND SER-834, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; THR-47; THR-51;SER-86; SER-113; SER-116; SER-125; SER-442; SER-446; SER-460; SER-544;SER-548; SER-552 AND SER-834, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-834, ANDMASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-302; SER-313; SER-576AND THR-585, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-86; SER-88;THR-97; SER-123; SER-125; SER-252; SER-460; SER-753 AND SER-834, ANDMASS SPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460; SER-544; SER-548;SER-552 AND SER-834, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-834, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399; SER-544; SER-548;SER-741 AND SER-834, AND MASS SPECTROMETRY.
Ubiquitylation
ReferencePubMed
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry.";
Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.;
Proteomics 7:868-874(2007).
Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-439, AND MASSSPECTROMETRY.

TOP